Search

Your search keyword '"Kaye, Stanley B."' showing total 383 results
Start Over Author "Kaye, Stanley B."
383 results on '"Kaye, Stanley B."'

1. Common variants at 19p13 are associated with susceptibility to ovarian cancer (vol 42, pg 880, 2010)

Author

Bolton, Kelly L, Tyrer, Jonathan, Song, Honglin, Ramus, Susan J, Notaridou, Maria, Jones, Chris, Sher, Tanya, Gentry-Maharaj, Aleksandra, Wozniak, Eva, Tsai, Ya-Yu, Weidhaas, Joanne, Paik, Daniel, Van den Berg, David J, Stram, Daniel O, Pearce, Celeste Leigh, Wu, Anna H, Brewster, Wendy, Anton-Culver, Hoda, Ziogas, Argyrios, Narod, Steven A, Levine, Douglas A, Kaye, Stanley B, Brown, Robert, Paul, Jim, Flanagan, James, Sieh, Weiva, McGuire, Valerie, Whittemore, Alice S, Campbell, Ian, Gore, Martin E, Lissowska, Jolanta, Yang, Hanna P, Medrek, Krzysztof, Gronwald, Jacek, Lubinski, Jan, Jakubowska, Anna, Le, Nhu D, Cook, Linda S, Kelemen, Linda E, Brooks-Wilson, Angela, Massuger, Leon FAG, Kiemeney, Lambertus A, Aben, Katja KH, van Altena, Anne M, Houlston, Richard, Tomlinson, Ian, Palmieri, Rachel T, Moorman, Patricia G, Schildkraut, Joellen, Iversen, Edwin S, Phelan, Catherine, Vierkant, Robert A, Cunningham, Julie M, Goode, Ellen L, Fridley, Brooke L, Kruger-Kjaer, Susan, Blaeker, Jan, Hogdall, Estrid, Hogdall, Claus, Gross, Jenny, Karlan, Beth Y, Ness, Roberta B, Edwards, Robert P, Odunsi, Kunle, Moyisch, Kirsten B, Baker, Julie A, Modugno, Francesmary, Heikkinenen, Tuomas, Butzow, Ralf, Nevanlinna, Heli, Leminen, Arto, Bogdanova, Natalia, Antonenkova, Natalia, Doerk, Thilo, Hillemanns, Peter, Duerst, Matthias, Runnebaum, Ingo, Thompson, Pamela J, Carney, Michael E, Goodman, Marc T, Lurie, Galina, Wang-Gohrke, Shan, Hein, Rebecca, Chang-Claude, Jenny, Rossing, Mary Anne, Cushing-Haugen, Kara L, Doherty, Jennifer, Chen, Chu, Rafnar, Thorunn, Besenbacher, Soren, Sulem, Patrick, Stefansson, Kari, Birrer, Michael J, Terry, Kathryn L, Hernandez, Dena, Cramer, Daniel W, Vergote, Ignace, Amant, Frederic, Lambrechts, Diether, and Despierre, Evelyn

Subjects
Developmental Biology, Biological Sciences, Medical and Health Sciences
Published
2016

2. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.

Author

Bolton, Kelly L, Tyrer, Jonathan, Song, Honglin, Ramus, Susan J, Notaridou, Maria, Jones, Chris, Sher, Tanya, Gentry-Maharaj, Aleksandra, Wozniak, Eva, Tsai, Ya-Yu, Weidhaas, Joanne, Paik, Daniel, Van Den Berg, David J, Stram, Daniel O, Pearce, Celeste Leigh, Wu, Anna H, Brewster, Wendy, Anton-Culver, Hoda, Ziogas, Argyrios, Narod, Steven A, Levine, Douglas A, Kaye, Stanley B, Brown, Robert, Paul, Jim, Flanagan, James, Sieh, Weiva, McGuire, Valerie, Whittemore, Alice S, Campbell, Ian, Gore, Martin E, Lissowska, Jolanta, Yang, Hanna P, Medrek, Krzysztof, Gronwald, Jacek, Lubinski, Jan, Jakubowska, Anna, Le, Nhu D, Cook, Linda S, Kelemen, Linda E, Brooks-Wilson, Angela, Massuger, Leon FAG, Kiemeney, Lambertus A, Aben, Katja KH, van Altena, Anne M, Houlston, Richard, Tomlinson, Ian, Palmieri, Rachel T, Moorman, Patricia G, Schildkraut, Joellen, Iversen, Edwin S, Phelan, Catherine, Vierkant, Robert A, Cunningham, Julie M, Goode, Ellen L, Fridley, Brooke L, Kruger-Kjaer, Susan, Blaeker, Jan, Hogdall, Estrid, Hogdall, Claus, Gross, Jenny, Karlan, Beth Y, Ness, Roberta B, Edwards, Robert P, Odunsi, Kunle, Moyisch, Kirsten B, Baker, Julie A, Modugno, Francesmary, Heikkinenen, Tuomas, Butzow, Ralf, Nevanlinna, Heli, Leminen, Arto, Bogdanova, Natalia, Antonenkova, Natalia, Doerk, Thilo, Hillemanns, Peter, Dürst, Matthias, Runnebaum, Ingo, Thompson, Pamela J, Carney, Michael E, Goodman, Marc T, Lurie, Galina, Wang-Gohrke, Shan, Hein, Rebecca, Chang-Claude, Jenny, Rossing, Mary Anne, Cushing-Haugen, Kara L, Doherty, Jennifer, Chen, Chu, Rafnar, Thorunn, Besenbacher, Soren, Sulem, Patrick, Stefansson, Kari, Birrer, Michael J, Terry, Kathryn L, Hernandez, Dena, Cramer, Daniel W, Vergote, Ignace, Amant, Frederic, Lambrechts, Diether, and Despierre, Evelyn

Subjects
Australian Ovarian Cancer Study Group, Rare Diseases, Cancer, Ovarian Cancer, Biological Sciences, Medical and Health Sciences, Developmental Biology
Published
2016

3. Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

Author

Block, Matthew S, Charbonneau, Bridget, Vierkant, Robert A, Fogarty, Zachary, Bamlet, William R, Pharoah, Paul DP, Chenevix-Trench, Georgia, AOCS, for, Group, ACS, Rossing, Mary Anne, Cramer, Daniel, Pearce, Celeste Leigh, Schildkraut, Joellen, Menon, Usha, Kjaer, Susanne K, Levine, Douglas A, Gronwald, Jacek, Culver, Hoda Anton, Whittemore, Alice S, Karlan, Beth Y, Lambrechts, Diether, Wentzensen, Nicolas, Kupryjanczyk, Jolanta, Chang-Claude, Jenny, Bandera, Elisa V, Hogdall, Estrid, Heitz, Florian, Kaye, Stanley B, Fasching, Peter A, Campbell, Ian, Goodman, Marc T, Pejovic, Tanja, Bean, Yukie T, Hays, Laura E, Lurie, Galina, Eccles, Diana, Hein, Alexander, Beckmann, Matthias W, Ekici, Arif B, Paul, James, Brown, Robert, Flanagan, James M, Harter, Philipp, du Bois, Andreas, Schwaab, Ira, Hogdall, Claus K, Lundvall, Lene, Olson, Sara H, Orlow, Irene, Paddock, Lisa E, Rudolph, Anja, Eilber, Ursula, Dansonka-Mieszkowska, Agnieszka, Rzepecka, Iwona K, Ziolkowska-Seta, Izabela, Brinton, Louise A, Yang, Hannah, Garcia-Closas, Montserrat, Despierre, Evelyn, Lambrechts, Sandrina, Vergote, Ignace, Walsh, Christine S, Lester, Jenny, Sieh, Weiva, McGuire, Valerie, Rothstein, Joseph H, Ziogas, Argyrios, Lubiński, Jan, Cybulski, Cezary, Menkiszak, Janusz, Jensen, Allan, Gayther, Simon A, Ramus, Susan J, Gentry-Maharaj, Aleksandra, Berchuck, Andrew, Wu, Anna H, Pike, Malcolm C, Van Den Berg, David, Terry, Kathryn L, Vitonis, Allison F, Ramirez, Starr M, Rider, David N, Knutson, Keith L, Sellers, Thomas A, Phelan, Catherine M, Doherty, Jennifer A, Johnatty, Sharon E, deFazio, Anna, Song, Honglin, Tyrer, Jonathan, Kalli, Kimberly R, Fridley, Brooke L, Cunningham, Julie M, and Goode, Ellen L

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Rare Diseases, Genetics, Women's Health, Cancer, Ovarian Cancer, 2.1 Biological and endogenous factors, Adult, Aged, Carcinoma, Ovarian Epithelial, Female, Genotype, Humans, Middle Aged, NF-kappa B, Neoplasm Invasiveness, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Polymorphism, Single Nucleotide, Proportional Hazards Models, Signal Transduction, Georgia Chenevix-Trench, for AOCS, /ACS Group, Medical and Health Sciences, Epidemiology, Biomedical and clinical sciences, Health sciences
Abstract

Survival in epithelial ovarian cancer (EOC) is influenced by the host immune response, yet the key genetic determinants of inflammation and immunity that affect prognosis are not known. The nuclear factor-κB (NF-κB) transcription factor family plays an important role in many immune and inflammatory responses, including the response to cancer. We studied common inherited variation in 210 genes in the NF-κB family in 10,084 patients with invasive EOC (5,248 high-grade serous, 1,452 endometrioid, 795 clear cell, and 661 mucinous) from the Ovarian Cancer Association Consortium. Associations between genotype and overall survival were assessed using Cox regression for all patients and by major histology, adjusting for known prognostic factors and correcting for multiple testing (threshold for statistical significance, P < 2.5 × 10(-5)). Results were statistically significant when assessed for patients of a single histology. Key associations were with caspase recruitment domain family, member 11 (CARD11) rs41324349 in patients with mucinous EOC [HR, 1.82; 95% confidence interval (CI), 1.41-2.35; P = 4.13 × 10(-6)] and tumor necrosis factor receptor superfamily, member 13B (TNFRSF13B) rs7501462 in patients with endometrioid EOC (HR, 0.68; 95% CI, 0.56-0.82; P = 2.33 × 10(-5)). Other associations of note included TNF receptor-associated factor 2 (TRAF2) rs17250239 in patients with high-grade serous EOC (HR, 0.84; 95% CI, 0.77-0.92; P = 6.49 × 10(-5)) and phospholipase C, gamma 1 (PLCG1) rs11696662 in patients with clear cell EOC (HR, 0.43; 95% CI, 0.26-0.73; P = 4.56 × 10(-4)). These associations highlight the potential importance of genes associated with host inflammation and immunity in modulating clinical outcomes in distinct EOC histologies.

Published
2014

4. Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

Author

Charbonneau, Bridget, Moysich, Kirsten B, Kalli, Kimberly R, Oberg, Ann L, Vierkant, Robert A, Fogarty, Zachary C, Block, Matthew S, Maurer, Matthew J, Goergen, Krista M, Fridley, Brooke L, Cunningham, Julie M, Rider, David N, Preston, Claudia, Hartmann, Lynn C, Lawrenson, Kate, Wang, Chen, Tyrer, Jonathan, Song, Honglin, deFazio, Anna, Johnatty, Sharon E, Doherty, Jennifer A, Phelan, Catherine M, Sellers, Thomas A, Ramirez, Starr M, Vitonis, Allison F, Terry, Kathryn L, Van Den Berg, David, Pike, Malcolm C, Wu, Anna H, Berchuck, Andrew, Gentry-Maharaj, Aleksandra, Ramus, Susan J, Diergaarde, Brenda, Shen, Howard, Jensen, Allan, Menkiszak, Janusz, Cybulski, Cezary, Lubiński, Jan, Ziogas, Argyrios, Rothstein, Joseph H, McGuire, Valerie, Sieh, Weiva, Lester, Jenny, Walsh, Christine, Vergote, Ignace, Lambrechts, Sandrina, Despierre, Evelyn, Garcia-Closas, Montserrat, Yang, Hannah, Brinton, Louise A, Spiewankiewicz, Beata, Rzepecka, Iwona K, Dansonka-Mieszkowska, Agnieszka, Seibold, Petra, Rudolph, Anja, Paddock, Lisa E, Orlow, Irene, Lundvall, Lene, Olson, Sara H, Hogdall, Claus K, Schwaab, Ira, du Bois, Andreas, Harter, Philipp, Flanagan, James M, Brown, Robert, Paul, James, Ekici, Arif B, Beckmann, Matthias W, Hein, Alexander, Eccles, Diana, Lurie, Galina, Hays, Laura E, Bean, Yukie T, Pejovic, Tanja, Goodman, Marc T, Campbell, Ian, Fasching, Peter A, Konecny, Gottfried, Kaye, Stanley B, Heitz, Florian, Hogdall, Estrid, Bandera, Elisa V, Chang-Claude, Jenny, Kupryjanczyk, Jolanta, Wentzensen, Nicolas, Lambrechts, Diether, Karlan, Beth Y, Whittemore, Alice S, Culver, Hoda Anton, Gronwald, Jacek, Levine, Douglas A, Kjaer, Susanne K, Menon, Usha, Schildkraut, Joellen M, Pearce, Celeste Leigh, Cramer, Daniel W, Rossing, Mary Anne, Chenevix-Trench, Georgia, group, for the AOCS, and ACS

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Ovarian Cancer, Cancer, Genetics, Clinical Research, Rare Diseases, Women's Health, 2.1 Biological and endogenous factors, Female, Gene Expression, Gene Expression Profiling, Genetic Predisposition to Disease, Genetic Variation, Germ-Line Mutation, Humans, Interleukin-2 Receptor alpha Subunit, Neoplasm Grading, Neoplasm Invasiveness, Ovarian Neoplasms, Patient Outcome Assessment, Polymorphism, Single Nucleotide, Prognosis, T-Lymphocytes, Regulatory, AOCS group, ACS, Pharmacology and Pharmaceutical Sciences, Oncology and carcinogenesis
Abstract

The presence of regulatory T cells (Treg) in solid tumors is known to play a role in patient survival in ovarian cancer and other malignancies. We assessed inherited genetic variations via 749 tag single-nucleotide polymorphisms (SNP) in 25 Treg-associated genes (CD28, CTLA4, FOXP3, IDO1, IL10, IL10RA, IL15, 1L17RA, IL23A, IL23R, IL2RA, IL6, IL6R, IL8, LGALS1, LGALS9, MAP3K8, STAT5A, STAT5B, TGFB1, TGFB2, TGFB3, TGFBR1, TGRBR2, and TGFBR3) in relation to ovarian cancer survival. We analyzed genotype and overall survival in 10,084 women with invasive epithelial ovarian cancer, including 5,248 high-grade serous, 1,452 endometrioid, 795 clear cell, and 661 mucinous carcinoma cases of European descent across 28 studies from the Ovarian Cancer Association Consortium (OCAC). The strongest associations were found for endometrioid carcinoma and IL2RA SNPs rs11256497 [HR, 1.42; 95% confidence interval (CI), 1.22-1.64; P = 5.7 × 10(-6)], rs791587 (HR, 1.36; 95% CI, 1.17-1.57; P = 6.2 × 10(-5)), rs2476491 (HR, = 1.40; 95% CI, 1.19-1.64; P = 5.6 × 10(-5)), and rs10795763 (HR, 1.35; 95% CI, 1.17-1.57; P = 7.9 × 10(-5)), and for clear cell carcinoma and CTLA4 SNP rs231775 (HR, 0.67; 95% CI, 0.54-0.82; P = 9.3 × 10(-5)) after adjustment for age, study site, population stratification, stage, grade, and oral contraceptive use. The rs231775 allele associated with improved survival in our study also results in an amino acid change in CTLA4 and previously has been reported to be associated with autoimmune conditions. Thus, we found evidence that SNPs in genes related to Tregs seem to play a role in ovarian cancer survival, particularly in patients with clear cell and endometrioid epithelial ovarian cancer.

Published
2014

5. Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

Author

Charbonneau, Bridget, Block, Matthew S, Bamlet, William R, Vierkant, Robert A, Kalli, Kimberly R, Fogarty, Zachary, Rider, David N, Sellers, Thomas A, Tworoger, Shelley S, Poole, Elizabeth, Risch, Harvey A, Salvesen, Helga B, Kiemeney, Lambertus A, Baglietto, Laura, Giles, Graham G, Severi, Gianluca, Trabert, Britton, Wentzensen, Nicolas, Chenevix-Trench, Georgia, group, for AOCS ACS, Whittemore, Alice S, Sieh, Weiva, Chang-Claude, Jenny, Bandera, Elisa V, Orlow, Irene, Terry, Kathryn, Goodman, Marc T, Thompson, Pamela J, Cook, Linda S, Rossing, Mary Anne, Ness, Roberta B, Narod, Steven A, Kupryjanczyk, Jolanta, Lu, Karen, Butzow, Ralf, Dörk, Thilo, Pejovic, Tanja, Campbell, Ian, Le, Nhu D, Bunker, Clareann H, Bogdanova, Natalia, Runnebaum, Ingo B, Eccles, Diana, Paul, James, Wu, Anna H, Gayther, Simon A, Hogdall, Estrid, Heitz, Florian, Kaye, Stanley B, Karlan, Beth Y, Anton-Culver, Hoda, Gronwald, Jacek, Hogdall, Claus K, Lambrechts, Diether, Fasching, Peter A, Menon, Usha, Schildkraut, Joellen, Pearce, Celeste Leigh, Levine, Douglas A, Kjaer, Susanne Kruger, Cramer, Daniel, Flanagan, James M, Phelan, Catherine M, Brown, Robert, Massuger, Leon FAG, Song, Honglin, Doherty, Jennifer A, Krakstad, Camilla, Liang, Dong, Odunsi, Kunle, Berchuck, Andrew, Jensen, Allan, Lubiński, Jan, Nevanlinna, Heli, Bean, Yukie T, Lurie, Galina, Ziogas, Argyrios, Walsh, Christine, Despierre, Evelyn, Brinton, Louise, Hein, Alexander, Rudolph, Anja, Dansonka-Mieszkowska, Agnieszka, Olson, Sara H, Harter, Philipp, Tyrer, Jonathan, Vitonis, Allison F, Brooks-Wilson, Angela, Aben, Katja K, Pike, Malcolm C, Ramus, Susan J, Wik, Elisabeth, Cybulski, Cezary, Lin, Jie, Sucheston, Lara, Edwards, Robert, McGuire, Valerie, Lester, Jenny, du Bois, Andreas, and Lundvall, Lene

Subjects
Biological Sciences, Biomedical and Clinical Sciences, Genetics, Oncology and Carcinogenesis, Ovarian Cancer, Cancer, Clinical Research, Rare Diseases, Human Genome, Women's Health, Prevention, 2.1 Biological and endogenous factors, Case-Control Studies, Female, Genetic Association Studies, Humans, Interleukin-1alpha, NF-kappa B, Ovarian Neoplasms, Polymorphism, Single Nucleotide, Risk, Signal Transduction, TNF-Related Apoptosis-Inducing Ligand, for AOCS/ACS group, Oncology & Carcinogenesis, Biochemistry and cell biology, Oncology and carcinogenesis
Abstract

A missense single-nucleotide polymorphism (SNP) in the immune modulatory gene IL1A has been associated with ovarian cancer risk (rs17561). Although the exact mechanism through which this SNP alters risk of ovarian cancer is not clearly understood, rs17561 has also been associated with risk of endometriosis, an epidemiologic risk factor for ovarian cancer. Interleukin-1α (IL1A) is both regulated by and able to activate NF-κB, a transcription factor family that induces transcription of many proinflammatory genes and may be an important mediator in carcinogenesis. We therefore tagged SNPs in more than 200 genes in the NF-κB pathway for a total of 2,282 SNPs (including rs17561) for genotype analysis of 15,604 cases of ovarian cancer in patients of European descent, including 6,179 of high-grade serous (HGS), 2,100 endometrioid, 1,591 mucinous, 1,034 clear cell, and 1,016 low-grade serous, including 23,235 control cases spanning 40 studies in the Ovarian Cancer Association Consortium. In this large population, we confirmed the association between rs17561 and clear cell ovarian cancer [OR, 0.84; 95% confidence interval (CI), 0.76-0.93; P = 0.00075], which remained intact even after excluding participants in the prior study (OR, 0.85; 95% CI, 0.75-0.95; P = 0.006). Considering a multiple-testing-corrected significance threshold of P < 2.5 × 10(-5), only one other variant, the TNFSF10 SNP rs6785617, was associated significantly with a risk of ovarian cancer (low malignant potential tumors OR, 0.85; 95% CI, 0.79-0.91; P = 0.00002). Our results extend the evidence that borderline tumors may have a distinct genetic etiology. Further investigation of how these SNPs might modify ovarian cancer associations with other inflammation-related risk factors is warranted.

Published
2014

6. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31

Author

Permuth-Wey, Jennifer, Lawrenson, Kate, Shen, Howard C, Velkova, Aneliya, Tyrer, Jonathan P, Chen, Zhihua, Lin, Hui-Yi, Ann Chen, Y, Tsai, Ya-Yu, Qu, Xiaotao, Ramus, Susan J, Karevan, Rod, Lee, Janet, Lee, Nathan, Larson, Melissa C, Aben, Katja K, Anton-Culver, Hoda, Antonenkova, Natalia, Antoniou, Antonis C, Armasu, Sebastian M, Bacot, François, Baglietto, Laura, Bandera, Elisa V, Barnholtz-Sloan, Jill, Beckmann, Matthias W, Birrer, Michael J, Bloom, Greg, Bogdanova, Natalia, Brinton, Louise A, Brooks-Wilson, Angela, Brown, Robert, Butzow, Ralf, Cai, Qiuyin, Campbell, Ian, Chang-Claude, Jenny, Chanock, Stephen, Chenevix-Trench, Georgia, Cheng, Jin Q, Cicek, Mine S, Coetzee, Gerhard A, Cook, Linda S, Couch, Fergus J, Cramer, Daniel W, Cunningham, Julie M, Dansonka-Mieszkowska, Agnieszka, Despierre, Evelyn, Doherty, Jennifer A, Dörk, Thilo, du Bois, Andreas, Dürst, Matthias, Easton, Douglas F, Eccles, Diana, Edwards, Robert, Ekici, Arif B, Fasching, Peter A, Fenstermacher, David A, Flanagan, James M, Garcia-Closas, Montserrat, Gentry-Maharaj, Aleksandra, Giles, Graham G, Glasspool, Rosalind M, Gonzalez-Bosquet, Jesus, Goodman, Marc T, Gore, Martin, Górski, Bohdan, Gronwald, Jacek, Hall, Per, Halle, Mari K, Harter, Philipp, Heitz, Florian, Hillemanns, Peter, Hoatlin, Maureen, Høgdall, Claus K, Høgdall, Estrid, Hosono, Satoyo, Jakubowska, Anna, Jensen, Allan, Jim, Heather, Kalli, Kimberly R, Karlan, Beth Y, Kaye, Stanley B, Kelemen, Linda E, Kiemeney, Lambertus A, Kikkawa, Fumitaka, Konecny, Gottfried E, Krakstad, Camilla, Krüger Kjaer, Susanne, Kupryjanczyk, Jolanta, Lambrechts, Diether, Lambrechts, Sandrina, Lancaster, Johnathan M, Le, Nhu D, Leminen, Arto, Levine, Douglas A, Liang, Dong, Kiong Lim, Boon, Lin, Jie, Lissowska, Jolanta, Lu, Karen H, and Lubiński, Jan

Subjects
Biological Sciences, Biomedical and Clinical Sciences, Genetics, Prevention, Cancer, Ovarian Cancer, Biotechnology, Human Genome, Genetic Testing, Rare Diseases, Women's Health, Clinical Research, 2.1 Biological and endogenous factors, Carcinoma, Ovarian Epithelial, Chromosomes, Human, Pair 17, Female, Genetic Predisposition to Disease, Humans, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Polymorphism, Single Nucleotide, Australian Cancer Study, Australian Ovarian Cancer Study, Consortium of Investigators of Modifiers of BRCA1/2
Abstract

Epithelial ovarian cancer (EOC) has a heritable component that remains to be fully characterized. Most identified common susceptibility variants lie in non-protein-coding sequences. We hypothesized that variants in the 3' untranslated region at putative microRNA (miRNA)-binding sites represent functional targets that influence EOC susceptibility. Here, we evaluate the association between 767 miRNA-related single-nucleotide polymorphisms (miRSNPs) and EOC risk in 18,174 EOC cases and 26,134 controls from 43 studies genotyped through the Collaborative Oncological Gene-environment Study. We identify several miRSNPs associated with invasive serous EOC risk (odds ratio=1.12, P=10(-8)) mapping to an inversion polymorphism at 17q21.31. Additional genotyping of non-miRSNPs at 17q21.31 reveals stronger signals outside the inversion (P=10(-10)). Variation at 17q21.31 is associated with neurological diseases, and our collaboration is the first to report an association with EOC susceptibility. An integrated molecular analysis in this region provides evidence for ARHGAP27 and PLEKHM1 as candidate EOC susceptibility genes.

Published
2013

7. Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium

Author

Amankwah, Ernest K., Wang, Qinggang, Schildkraut, Joellen M., Tsai, Ya-Yu, Ramus, Susan J., Fridley, Brooke L., Beesley, Jonathan, Johnatty, Sharon E., Webb, Penelope M., Chenevix-Trench, Georgia, Dale, Laura C., Lambrechts, Diether, Amant, Frederic, Despierre, Evelyn, Vergote, Ignace, Gayther, Simon A., Gentry-Maharaj, Aleksandra, Menon, Usha, Chang-Claude, Jenny, Wang-Gohrke, Shan, Anton-Culver, Hoda, Ziogas, Argyrios, Dork, Thilo, Durst, Matthias, Antonenkova, Natalia, Bogdanova, Natalia, Brown, Robert, Flanagan, James M., Kaye, Stanley B., Paul, James, Butzow, Ralf, Nevanlinna, Heli, Campbell, Ian, Eccles, Diana M., Karlan, Beth Y., Gross, Jenny, Walsh, Christine, Pharoah, Paul P., Song, Honglin, Kruger Kjaer, Susanne, H?gdall, Estrid, H?gdall, Claus, Lundvall, Lene, Nedergaard, Lotte, Kiemeney, Lambertus M., Massuger, Leon G., van Altena, Anne M., Vermeulen, Sita M., Le, Nhu D., Brooks-Wilson, Angela, Cook, Linda S., Phelan, Catherine M., Cunningham, Julie M., Vachon, Celine M., Vierkant, Robert A., Iversen, Edwin S., Berchuck, Andrew, Goode, Ellen L., Sellers, Thomas A., and Kelemen, Linda E.

Subjects
growth-factor-beta, genome-wide association, mammary-gland, tgf-beta, oral-contraceptives, expression, decorin, risk, carcinoma, trends
Abstract

Alterations in stromal tissue components can inhibit or promote epithelial tumorigenesis. Decorin (DCN) and lumican (LUM) show reduced stromal expression in serous epithelial ovarian cancer (sEOC). We hypothesized that common variants in these genes associate with risk. Associations with sEOC among Caucasians were estimated with odds ratios (OR) among 397 cases and 920 controls in two U.S.-based studies (discovery set), 436 cases and 1,098 controls in Australia (replication set 1) and a consortium of 15 studies comprising 1,668 cases and 4,249 controls (replication set 2). The discovery set and replication set 1 (833 cases and 2,013 controls) showed statistically homogeneous (Pheterogeneity≥0.48) decreased risks of sEOC at four variants: DCN rs3138165, rs13312816 and rs516115, and LUM rs17018765 (OR = 0.6 to 0.9; Ptrend = 0.001 to 0.03). Results from replication set 2 were statistically homogeneous (Pheterogeneity≥0.13) and associated with increased risks at DCN rs3138165 and rs13312816, and LUM rs17018765: all ORs = 1.2; Ptrend≤0.02. The ORs at the four variants were statistically heterogeneous across all 18 studies (Pheterogeneity≤0.03), which precluded combining. In post-hoc analyses, interactions were observed between each variant and recruitment period (Pinteraction≤0.003), age at diagnosis (Pinteraction = 0.04), and year of diagnosis (Pinteraction = 0.05) in the five studies with available information (1,044 cases, 2,469 controls). We conclude that variants in DCN and LUM are not directly associated with sEOC, and that confirmation of possible effect modification of the variants by non-genetic factors is required.

Published
2011

8. Common variants at 19p13 are associated with susceptibility to ovarian cancer.

Author

Bolton, Kelly L, Tyrer, Jonathan, Song, Honglin, Ramus, Susan J, Notaridou, Maria, Jones, Chris, Sher, Tanya, Gentry-Maharaj, Aleksandra, Wozniak, Eva, Tsai, Ya-Yu, Weidhaas, Joanne, Paik, Daniel, Van Den Berg, David J, Stram, Daniel O, Pearce, Celeste Leigh, Wu, Anna H, Brewster, Wendy, Anton-Culver, Hoda, Ziogas, Argyrios, Narod, Steven A, Levine, Douglas A, Kaye, Stanley B, Brown, Robert, Paul, Jim, Flanagan, James, Sieh, Weiva, McGuire, Valerie, Whittemore, Alice S, Campbell, Ian, Gore, Martin E, Lissowska, Jolanta, Yang, Hanna P, Medrek, Krzysztof, Gronwald, Jacek, Lubinski, Jan, Jakubowska, Anna, Le, Nhu D, Cook, Linda S, Kelemen, Linda E, Brooks-Wilson, Angela, Massuger, Leon FAG, Kiemeney, Lambertus A, Aben, Katja KH, van Altena, Anne M, Houlston, Richard, Tomlinson, Ian, Palmieri, Rachel T, Moorman, Patricia G, Schildkraut, Joellen, Iversen, Edwin S, Phelan, Catherine, Vierkant, Robert A, Cunningham, Julie M, Goode, Ellen L, Fridley, Brooke L, Kruger-Kjaer, Susan, Blaeker, Jan, Hogdall, Estrid, Hogdall, Claus, Gross, Jenny, Karlan, Beth Y, Ness, Roberta B, Edwards, Robert P, Odunsi, Kunle, Moyisch, Kirsten B, Baker, Julie A, Modugno, Francesmary, Heikkinenen, Tuomas, Butzow, Ralf, Nevanlinna, Heli, Leminen, Arto, Bogdanova, Natalia, Antonenkova, Natalia, Doerk, Thilo, Hillemanns, Peter, Dürst, Matthias, Runnebaum, Ingo, Thompson, Pamela J, Carney, Michael E, Goodman, Marc T, Lurie, Galina, Wang-Gohrke, Shan, Hein, Rebecca, Chang-Claude, Jenny, Rossing, Mary Anne, Cushing-Haugen, Kara L, Doherty, Jennifer, Chen, Chu, Rafnar, Thorunn, Besenbacher, Soren, Sulem, Patrick, Stefansson, Kari, Birrer, Michael J, Terry, Kathryn L, Hernandez, Dena, Cramer, Daniel W, Vergote, Ignace, Amant, Frederic, Lambrechts, Diether, and Despierre, Evelyn

Subjects
Australian Ovarian Cancer Study Group, Australian Cancer Study, Ovarian Cancer Association Consortium, Ovary, Tumor Cells, Cultured, Chromosomes, Human, Pair 19, Humans, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, Cystadenocarcinoma, Serous, Ovarian Neoplasms, Endometrial Neoplasms, Genetic Predisposition to Disease, Adaptor Proteins, Signal Transducing, Oligonucleotide Array Sequence Analysis, Case-Control Studies, Gene Expression Profiling, Genotype, Polymorphism, Single Nucleotide, Genome, Human, Middle Aged, Female, Genome-Wide Association Study, Biomarkers, Tumor, Tumor Cells, Cultured, Chromosomes, Human, Pair 19, Adenocarcinoma, Clear Cell, Mucinous, Cystadenocarcinoma, Serous, Adaptor Proteins, Signal Transducing, Polymorphism, Single Nucleotide, Genome, Biomarkers, Tumor, Cancer, Human Genome, Genetics, Ovarian Cancer, Orphan Drug, Rare Diseases, 2.1 Biological and endogenous factors, Developmental Biology, Medical and Health Sciences, Biological Sciences
Abstract

Epithelial ovarian cancer (EOC) is the leading cause of death from gynecological malignancy in the developed world, accounting for 4% of the deaths from cancer in women. We performed a three-phase genome-wide association study of EOC survival in 8,951 individuals with EOC (cases) with available survival time data and a parallel association analysis of EOC susceptibility. Two SNPs at 19p13.11, rs8170 and rs2363956, showed evidence of association with survival (overall P = 5 × 10⁻⁴ and P = 6 × 10⁻⁴, respectively), but they did not replicate in phase 3. However, the same two SNPs demonstrated genome-wide significance for risk of serous EOC (P = 3 × 10⁻⁹ and P = 4 × 10⁻¹¹, respectively). Expression analysis of candidate genes at this locus in ovarian tumors supported a role for the BRCA1-interacting gene C19orf62, also known as MERIT40, which contains rs8170, in EOC development.

Published
2010

12. Data from Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

Author

Charbonneau, Bridget, primary, Moysich, Kirsten B., primary, Kalli, Kimberly R., primary, Oberg, Ann L., primary, Vierkant, Robert A., primary, Fogarty, Zachary C., primary, Block, Matthew S., primary, Maurer, Matthew J., primary, Goergen, Krista M., primary, Fridley, Brooke L., primary, Cunningham, Julie M., primary, Rider, David N., primary, Preston, Claudia, primary, Hartmann, Lynn C., primary, Lawrenson, Kate, primary, Wang, Chen, primary, Tyrer, Jonathan, primary, Song, Honglin, primary, deFazio, Anna, primary, Johnatty, Sharon E., primary, Doherty, Jennifer A., primary, Phelan, Catherine M., primary, Sellers, Thomas A., primary, Ramirez, Starr M., primary, Vitonis, Allison F., primary, Terry, Kathryn L., primary, Van Den Berg, David, primary, Pike, Malcolm C., primary, Wu, Anna H., primary, Berchuck, Andrew, primary, Gentry-Maharaj, Aleksandra, primary, Ramus, Susan J., primary, Diergaarde, Brenda, primary, Shen, Howard, primary, Jensen, Allan, primary, Menkiszak, Janusz, primary, Cybulski, Cezary, primary, Lubiński, Jan, primary, Ziogas, Argyrios, primary, Rothstein, Joseph H., primary, McGuire, Valerie, primary, Sieh, Weiva, primary, Lester, Jenny, primary, Walsh, Christine, primary, Vergote, Ignace, primary, Lambrechts, Sandrina, primary, Despierre, Evelyn, primary, Garcia-Closas, Montserrat, primary, Yang, Hannah, primary, Brinton, Louise A., primary, Spiewankiewicz, Beata, primary, Rzepecka, Iwona K., primary, Dansonka-Mieszkowska, Agnieszka, primary, Seibold, Petra, primary, Rudolph, Anja, primary, Paddock, Lisa E., primary, Orlow, Irene, primary, Lundvall, Lene, primary, Olson, Sara H., primary, Hogdall, Claus K., primary, Schwaab, Ira, primary, du Bois, Andreas, primary, Harter, Philipp, primary, Flanagan, James M., primary, Brown, Robert, primary, Paul, James, primary, Ekici, Arif B., primary, Beckmann, Matthias W., primary, Hein, Alexander, primary, Eccles, Diana, primary, Lurie, Galina, primary, Hays, Laura E., primary, Bean, Yukie T., primary, Pejovic, Tanja, primary, Goodman, Marc T., primary, Campbell, Ian, primary, Fasching, Peter A., primary, Konecny, Gottfried, primary, Kaye, Stanley B., primary, Heitz, Florian, primary, Hogdall, Estrid, primary, Bandera, Elisa V., primary, Chang-Claude, Jenny, primary, Kupryjanczyk, Jolanta, primary, Wentzensen, Nicolas, primary, Lambrechts, Diether, primary, Karlan, Beth Y., primary, Whittemore, Alice S., primary, Culver, Hoda Anton, primary, Gronwald, Jacek, primary, Levine, Douglas A., primary, Kjaer, Susanne K., primary, Menon, Usha, primary, Schildkraut, Joellen M., primary, Pearce, Celeste Leigh, primary, Cramer, Daniel W., primary, Rossing, Mary Anne, primary, Chenevix-Trench, Georgia, primary, Pharoah, Paul D.P., primary, Gayther, Simon A., primary, Ness, Roberta B., primary, Odunsi, Kunle, primary, Sucheston, Lara E., primary, Knutson, Keith L., primary, and Goode, Ellen L., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Figure 1 from Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma

Author

Ang, Joo Ern, primary, Pal, Akos, primary, Asad, Yasmin J., primary, Henley, Alan T., primary, Valenti, Melanie, primary, Box, Gary, primary, de haven Brandon, Alexis, primary, Revell, Victoria L., primary, Skene, Debra J., primary, Venturi, Miro, primary, Rueger, Ruediger, primary, Meresse, Valerie, primary, Eccles, Suzanne A., primary, de Bono, Johann S., primary, Kaye, Stanley B., primary, Workman, Paul, primary, Banerji, Udai, primary, and Raynaud, Florence I., primary

Published
2023
Full Text
View/download PDF

14. Supplementary Table 1 from Ovarian Cancer Stem Cell–Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2

Author

Rizzo, Siân, primary, Hersey, Jenny M., primary, Mellor, Paul, primary, Dai, Wei, primary, Santos-Silva, Alessandra, primary, Liber, Daniel, primary, Luk, Louisa, primary, Titley, Ian, primary, Carden, Craig P, primary, Box, Garry, primary, Hudson, David L., primary, Kaye, Stanley B., primary, and Brown, Robert, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table 1 from Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma

Author

Ang, Joo Ern, primary, Pal, Akos, primary, Asad, Yasmin J., primary, Henley, Alan T., primary, Valenti, Melanie, primary, Box, Gary, primary, de haven Brandon, Alexis, primary, Revell, Victoria L., primary, Skene, Debra J., primary, Venturi, Miro, primary, Rueger, Ruediger, primary, Meresse, Valerie, primary, Eccles, Suzanne A., primary, de Bono, Johann S., primary, Kaye, Stanley B., primary, Workman, Paul, primary, Banerji, Udai, primary, and Raynaud, Florence I., primary

Published
2023
Full Text
View/download PDF

16. Supplementary Table 2 from Ovarian Cancer Stem Cell–Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2

Author

Rizzo, Siân, primary, Hersey, Jenny M., primary, Mellor, Paul, primary, Dai, Wei, primary, Santos-Silva, Alessandra, primary, Liber, Daniel, primary, Luk, Louisa, primary, Titley, Ian, primary, Carden, Craig P, primary, Box, Garry, primary, Hudson, David L., primary, Kaye, Stanley B., primary, and Brown, Robert, primary

Published
2023
Full Text
View/download PDF

17. Data from Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma

Author

Ang, Joo Ern, primary, Pal, Akos, primary, Asad, Yasmin J., primary, Henley, Alan T., primary, Valenti, Melanie, primary, Box, Gary, primary, de haven Brandon, Alexis, primary, Revell, Victoria L., primary, Skene, Debra J., primary, Venturi, Miro, primary, Rueger, Ruediger, primary, Meresse, Valerie, primary, Eccles, Suzanne A., primary, de Bono, Johann S., primary, Kaye, Stanley B., primary, Workman, Paul, primary, Banerji, Udai, primary, and Raynaud, Florence I., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Tables 1 - 4 from Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

Author

Charbonneau, Bridget, primary, Moysich, Kirsten B., primary, Kalli, Kimberly R., primary, Oberg, Ann L., primary, Vierkant, Robert A., primary, Fogarty, Zachary C., primary, Block, Matthew S., primary, Maurer, Matthew J., primary, Goergen, Krista M., primary, Fridley, Brooke L., primary, Cunningham, Julie M., primary, Rider, David N., primary, Preston, Claudia, primary, Hartmann, Lynn C., primary, Lawrenson, Kate, primary, Wang, Chen, primary, Tyrer, Jonathan, primary, Song, Honglin, primary, deFazio, Anna, primary, Johnatty, Sharon E., primary, Doherty, Jennifer A., primary, Phelan, Catherine M., primary, Sellers, Thomas A., primary, Ramirez, Starr M., primary, Vitonis, Allison F., primary, Terry, Kathryn L., primary, Van Den Berg, David, primary, Pike, Malcolm C., primary, Wu, Anna H., primary, Berchuck, Andrew, primary, Gentry-Maharaj, Aleksandra, primary, Ramus, Susan J., primary, Diergaarde, Brenda, primary, Shen, Howard, primary, Jensen, Allan, primary, Menkiszak, Janusz, primary, Cybulski, Cezary, primary, Lubiński, Jan, primary, Ziogas, Argyrios, primary, Rothstein, Joseph H., primary, McGuire, Valerie, primary, Sieh, Weiva, primary, Lester, Jenny, primary, Walsh, Christine, primary, Vergote, Ignace, primary, Lambrechts, Sandrina, primary, Despierre, Evelyn, primary, Garcia-Closas, Montserrat, primary, Yang, Hannah, primary, Brinton, Louise A., primary, Spiewankiewicz, Beata, primary, Rzepecka, Iwona K., primary, Dansonka-Mieszkowska, Agnieszka, primary, Seibold, Petra, primary, Rudolph, Anja, primary, Paddock, Lisa E., primary, Orlow, Irene, primary, Lundvall, Lene, primary, Olson, Sara H., primary, Hogdall, Claus K., primary, Schwaab, Ira, primary, du Bois, Andreas, primary, Harter, Philipp, primary, Flanagan, James M., primary, Brown, Robert, primary, Paul, James, primary, Ekici, Arif B., primary, Beckmann, Matthias W., primary, Hein, Alexander, primary, Eccles, Diana, primary, Lurie, Galina, primary, Hays, Laura E., primary, Bean, Yukie T., primary, Pejovic, Tanja, primary, Goodman, Marc T., primary, Campbell, Ian, primary, Fasching, Peter A., primary, Konecny, Gottfried, primary, Kaye, Stanley B., primary, Heitz, Florian, primary, Hogdall, Estrid, primary, Bandera, Elisa V., primary, Chang-Claude, Jenny, primary, Kupryjanczyk, Jolanta, primary, Wentzensen, Nicolas, primary, Lambrechts, Diether, primary, Karlan, Beth Y., primary, Whittemore, Alice S., primary, Culver, Hoda Anton, primary, Gronwald, Jacek, primary, Levine, Douglas A., primary, Kjaer, Susanne K., primary, Menon, Usha, primary, Schildkraut, Joellen M., primary, Pearce, Celeste Leigh, primary, Cramer, Daniel W., primary, Rossing, Mary Anne, primary, Chenevix-Trench, Georgia, primary, Pharoah, Paul D.P., primary, Gayther, Simon A., primary, Ness, Roberta B., primary, Odunsi, Kunle, primary, Sucheston, Lara E., primary, Knutson, Keith L., primary, and Goode, Ellen L., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Table 1 from A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission

Author

Kaye, Stanley B., primary, Fehrenbacher, Louis, primary, Holloway, Robert, primary, Amit, Amnon, primary, Karlan, Beth, primary, Slomovitz, Brian, primary, Sabbatini, Paul, primary, Fu, Ling, primary, Yauch, Robert L., primary, Chang, Ilsung, primary, and Reddy, Josina C., primary

Published
2023
Full Text
View/download PDF

20. Data from Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

Author

Block, Matthew S., primary, Charbonneau, Bridget, primary, Vierkant, Robert A., primary, Fogarty, Zachary, primary, Bamlet, William R., primary, Pharoah, Paul D.P., primary, Rossing, Mary Anne, primary, Cramer, Daniel, primary, Pearce, Celeste Leigh, primary, Schildkraut, Joellen, primary, Menon, Usha, primary, Kjaer, Susanne K., primary, Levine, Douglas A., primary, Gronwald, Jacek, primary, Culver, Hoda Anton, primary, Whittemore, Alice S., primary, Karlan, Beth Y., primary, Lambrechts, Diether, primary, Wentzensen, Nicolas, primary, Kupryjanczyk, Jolanta, primary, Chang-Claude, Jenny, primary, Bandera, Elisa V., primary, Hogdall, Estrid, primary, Heitz, Florian, primary, Kaye, Stanley B., primary, Fasching, Peter A., primary, Campbell, Ian, primary, Goodman, Marc T., primary, Pejovic, Tanja, primary, Bean, Yukie T., primary, Hays, Laura E., primary, Lurie, Galina, primary, Eccles, Diana, primary, Hein, Alexander, primary, Beckmann, Matthias W., primary, Ekici, Arif B., primary, Paul, James, primary, Brown, Robert, primary, Flanagan, James M., primary, Harter, Philipp, primary, du Bois, Andreas, primary, Schwaab, Ira, primary, Hogdall, Claus K., primary, Lundvall, Lene, primary, Olson, Sara H., primary, Orlow, Irene, primary, Paddock, Lisa E., primary, Rudolph, Anja, primary, Eilber, Ursula, primary, Dansonka-Mieszkowska, Agnieszka, primary, Rzepecka, Iwona K., primary, Ziolkowska-Seta, Izabela, primary, Brinton, Louise A., primary, Yang, Hannah, primary, Garcia-Closas, Montserrat, primary, Despierre, Evelyn, primary, Lambrechts, Sandrina, primary, Vergote, Ignace, primary, Walsh, Christine S., primary, Lester, Jenny, primary, Sieh, Weiva, primary, McGuire, Valerie, primary, Rothstein, Joseph H., primary, Ziogas, Argyrios, primary, Lubiński, Jan, primary, Cybulski, Cezary, primary, Menkiszak, Janusz, primary, Jensen, Allan, primary, Gayther, Simon A., primary, Ramus, Susan J., primary, Gentry-Maharaj, Aleksandra, primary, Berchuck, Andrew, primary, Wu, Anna H., primary, Pike, Malcolm C., primary, Van Den Berg, David, primary, Terry, Kathryn L., primary, Vitonis, Allison F., primary, Ramirez, Starr M., primary, Rider, David N., primary, Knutson, Keith L., primary, Sellers, Thomas A., primary, Phelan, Catherine M., primary, Doherty, Jennifer A., primary, Johnatty, Sharon E., primary, deFazio, Anna, primary, Song, Honglin, primary, Tyrer, Jonathan, primary, Kalli, Kimberly R., primary, Fridley, Brooke L., primary, Cunningham, Julie M., primary, and Goode, Ellen L., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure 1 from Higher Risk of Infections with PI3K–AKT–mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials

Author

Rafii, Saeed, primary, Roda, Desamparados, primary, Geuna, Elena, primary, Jimenez, Begona, primary, Rihawi, Karim, primary, Capelan, Marta, primary, Yap, Timothy A., primary, Molife, L. Rhoda, primary, Kaye, Stanley B., primary, de Bono, Johann S., primary, and Banerji, Udai, primary

Published
2023
Full Text
View/download PDF

22. Supplementary Data from Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas

Author

Tan, David S.P., primary, Iravani, Marjan, primary, McCluggage, W. Glenn, primary, Lambros, Maryou B.K., primary, Milanezi, Fernanda, primary, Mackay, Alan, primary, Gourley, Charles, primary, Geyer, Felipe C., primary, Vatcheva, Radost, primary, Millar, Joanne, primary, Thomas, Karen, primary, Natrajan, Rachael, primary, Savage, Kay, primary, Fenwick, Kerry, primary, Williams, Alistair, primary, Jameson, Charles, primary, El-Bahrawy, Mona, primary, Gore, Martin E., primary, Gabra, Hani, primary, Kaye, Stanley B., primary, Ashworth, Alan, primary, and Reis-Filho, Jorge S., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Table Legend from A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission

Author

Kaye, Stanley B., primary, Fehrenbacher, Louis, primary, Holloway, Robert, primary, Amit, Amnon, primary, Karlan, Beth, primary, Slomovitz, Brian, primary, Sabbatini, Paul, primary, Fu, Ling, primary, Yauch, Robert L., primary, Chang, Ilsung, primary, and Reddy, Josina C., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Data from PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas

Author

Tan, David S.P., primary, Lambros, Maryou B.K., primary, Rayter, Sydonia, primary, Natrajan, Rachael, primary, Vatcheva, Radost, primary, Gao, Qiong, primary, Marchiò, Caterina, primary, Geyer, Felipe C., primary, Savage, Kay, primary, Parry, Suzanne, primary, Fenwick, Kerry, primary, Tamber, Narinder, primary, Mackay, Alan, primary, Dexter, Tim, primary, Jameson, Charles, primary, McCluggage, W. Glenn, primary, Williams, Alistair, primary, Graham, Ashley, primary, Faratian, Dana, primary, El-Bahrawy, Mona, primary, Paige, Adam J., primary, Gabra, Hani, primary, Gore, Martin E., primary, Zvelebil, Marketa, primary, Lord, Christopher J., primary, Kaye, Stanley B., primary, Ashworth, Alan, primary, and Reis-Filho, Jorge S., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Tables 1 through 3 from Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

Author

Block, Matthew S., primary, Charbonneau, Bridget, primary, Vierkant, Robert A., primary, Fogarty, Zachary, primary, Bamlet, William R., primary, Pharoah, Paul D.P., primary, Rossing, Mary Anne, primary, Cramer, Daniel, primary, Pearce, Celeste Leigh, primary, Schildkraut, Joellen, primary, Menon, Usha, primary, Kjaer, Susanne K., primary, Levine, Douglas A., primary, Gronwald, Jacek, primary, Culver, Hoda Anton, primary, Whittemore, Alice S., primary, Karlan, Beth Y., primary, Lambrechts, Diether, primary, Wentzensen, Nicolas, primary, Kupryjanczyk, Jolanta, primary, Chang-Claude, Jenny, primary, Bandera, Elisa V., primary, Hogdall, Estrid, primary, Heitz, Florian, primary, Kaye, Stanley B., primary, Fasching, Peter A., primary, Campbell, Ian, primary, Goodman, Marc T., primary, Pejovic, Tanja, primary, Bean, Yukie T., primary, Hays, Laura E., primary, Lurie, Galina, primary, Eccles, Diana, primary, Hein, Alexander, primary, Beckmann, Matthias W., primary, Ekici, Arif B., primary, Paul, James, primary, Brown, Robert, primary, Flanagan, James M., primary, Harter, Philipp, primary, du Bois, Andreas, primary, Schwaab, Ira, primary, Hogdall, Claus K., primary, Lundvall, Lene, primary, Olson, Sara H., primary, Orlow, Irene, primary, Paddock, Lisa E., primary, Rudolph, Anja, primary, Eilber, Ursula, primary, Dansonka-Mieszkowska, Agnieszka, primary, Rzepecka, Iwona K., primary, Ziolkowska-Seta, Izabela, primary, Brinton, Louise A., primary, Yang, Hannah, primary, Garcia-Closas, Montserrat, primary, Despierre, Evelyn, primary, Lambrechts, Sandrina, primary, Vergote, Ignace, primary, Walsh, Christine S., primary, Lester, Jenny, primary, Sieh, Weiva, primary, McGuire, Valerie, primary, Rothstein, Joseph H., primary, Ziogas, Argyrios, primary, Lubiński, Jan, primary, Cybulski, Cezary, primary, Menkiszak, Janusz, primary, Jensen, Allan, primary, Gayther, Simon A., primary, Ramus, Susan J., primary, Gentry-Maharaj, Aleksandra, primary, Berchuck, Andrew, primary, Wu, Anna H., primary, Pike, Malcolm C., primary, Van Den Berg, David, primary, Terry, Kathryn L., primary, Vitonis, Allison F., primary, Ramirez, Starr M., primary, Rider, David N., primary, Knutson, Keith L., primary, Sellers, Thomas A., primary, Phelan, Catherine M., primary, Doherty, Jennifer A., primary, Johnatty, Sharon E., primary, deFazio, Anna, primary, Song, Honglin, primary, Tyrer, Jonathan, primary, Kalli, Kimberly R., primary, Fridley, Brooke L., primary, Cunningham, Julie M., primary, and Goode, Ellen L., primary

Published
2023
Full Text
View/download PDF

26. Data from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

Author

Charbonneau, Bridget, primary, Block, Matthew S., primary, Bamlet, William R., primary, Vierkant, Robert A., primary, Kalli, Kimberly R., primary, Fogarty, Zachary, primary, Rider, David N., primary, Sellers, Thomas A., primary, Tworoger, Shelley S., primary, Poole, Elizabeth, primary, Risch, Harvey A., primary, Salvesen, Helga B., primary, Kiemeney, Lambertus A., primary, Baglietto, Laura, primary, Giles, Graham G., primary, Severi, Gianluca, primary, Trabert, Britton, primary, Wentzensen, Nicolas, primary, Chenevix-Trench, Georgia, primary, Whittemore, Alice S., primary, Sieh, Weiva, primary, Chang-Claude, Jenny, primary, Bandera, Elisa V., primary, Orlow, Irene, primary, Terry, Kathryn, primary, Goodman, Marc T., primary, Thompson, Pamela J., primary, Cook, Linda S., primary, Rossing, Mary Anne, primary, Ness, Roberta B., primary, Narod, Steven A., primary, Kupryjanczyk, Jolanta, primary, Lu, Karen, primary, Butzow, Ralf, primary, Dörk, Thilo, primary, Pejovic, Tanja, primary, Campbell, Ian, primary, Le, Nhu D., primary, Bunker, Clareann H., primary, Bogdanova, Natalia, primary, Runnebaum, Ingo B., primary, Eccles, Diana, primary, Paul, James, primary, Wu, Anna H., primary, Gayther, Simon A., primary, Hogdall, Estrid, primary, Heitz, Florian, primary, Kaye, Stanley B., primary, Karlan, Beth Y., primary, Anton-Culver, Hoda, primary, Gronwald, Jacek, primary, Hogdall, Claus K., primary, Lambrechts, Diether, primary, Fasching, Peter A., primary, Menon, Usha, primary, Schildkraut, Joellen, primary, Pearce, Celeste Leigh, primary, Levine, Douglas A., primary, Kjaer, Susanne Kruger, primary, Cramer, Daniel, primary, Flanagan, James M., primary, Phelan, Catherine M., primary, Brown, Robert, primary, Massuger, Leon F.A.G., primary, Song, Honglin, primary, Doherty, Jennifer A., primary, Krakstad, Camilla, primary, Liang, Dong, primary, Odunsi, Kunle, primary, Berchuck, Andrew, primary, Jensen, Allan, primary, Lubiński, Jan, primary, Nevanlinna, Heli, primary, Bean, Yukie T., primary, Lurie, Galina, primary, Ziogas, Argyrios, primary, Walsh, Christine, primary, Despierre, Evelyn, primary, Brinton, Louise, primary, Hein, Alexander, primary, Rudolph, Anja, primary, Dansonka-Mieszkowska, Agnieszka, primary, Olson, Sara H., primary, Harter, Philipp, primary, Tyrer, Jonathan, primary, Vitonis, Allison F., primary, Brooks-Wilson, Angela, primary, Aben, Katja K., primary, Pike, Malcolm C., primary, Ramus, Susan J., primary, Wik, Elisabeth, primary, Cybulski, Cezary, primary, Lin, Jie, primary, Sucheston, Lara, primary, Edwards, Robert, primary, McGuire, Valerie, primary, Lester, Jenny, primary, du Bois, Andreas, primary, Lundvall, Lene, primary, Wang-Gohrke, Shan, primary, Szafron, Lukasz M., primary, Lambrechts, Sandrina, primary, Yang, Hannah, primary, Beckmann, Matthias W., primary, Pelttari, Liisa M., primary, Van Altena, Anne M., primary, van den Berg, David, primary, Halle, Mari K., primary, Gentry-Maharaj, Aleksandra, primary, Schwaab, Ira, primary, Chandran, Urmila, primary, Menkiszak, Janusz, primary, Ekici, Arif B., primary, Wilkens, Lynne R., primary, Leminen, Arto, primary, Modugno, Francesmary, primary, Friel, Grace, primary, Rothstein, Joseph H., primary, Vergote, Ignace, primary, Garcia-Closas, Montserrat, primary, Hildebrandt, Michelle A.T., primary, Sobiczewski, Piotr, primary, Kelemen, Linda E., primary, Pharoah, Paul D.P., primary, Moysich, Kirsten, primary, Knutson, Keith L., primary, Cunningham, Julie M., primary, Fridley, Brooke L., primary, and Goode, Ellen L., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Tables 1 - 5 from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

Author

Charbonneau, Bridget, primary, Block, Matthew S., primary, Bamlet, William R., primary, Vierkant, Robert A., primary, Kalli, Kimberly R., primary, Fogarty, Zachary, primary, Rider, David N., primary, Sellers, Thomas A., primary, Tworoger, Shelley S., primary, Poole, Elizabeth, primary, Risch, Harvey A., primary, Salvesen, Helga B., primary, Kiemeney, Lambertus A., primary, Baglietto, Laura, primary, Giles, Graham G., primary, Severi, Gianluca, primary, Trabert, Britton, primary, Wentzensen, Nicolas, primary, Chenevix-Trench, Georgia, primary, Whittemore, Alice S., primary, Sieh, Weiva, primary, Chang-Claude, Jenny, primary, Bandera, Elisa V., primary, Orlow, Irene, primary, Terry, Kathryn, primary, Goodman, Marc T., primary, Thompson, Pamela J., primary, Cook, Linda S., primary, Rossing, Mary Anne, primary, Ness, Roberta B., primary, Narod, Steven A., primary, Kupryjanczyk, Jolanta, primary, Lu, Karen, primary, Butzow, Ralf, primary, Dörk, Thilo, primary, Pejovic, Tanja, primary, Campbell, Ian, primary, Le, Nhu D., primary, Bunker, Clareann H., primary, Bogdanova, Natalia, primary, Runnebaum, Ingo B., primary, Eccles, Diana, primary, Paul, James, primary, Wu, Anna H., primary, Gayther, Simon A., primary, Hogdall, Estrid, primary, Heitz, Florian, primary, Kaye, Stanley B., primary, Karlan, Beth Y., primary, Anton-Culver, Hoda, primary, Gronwald, Jacek, primary, Hogdall, Claus K., primary, Lambrechts, Diether, primary, Fasching, Peter A., primary, Menon, Usha, primary, Schildkraut, Joellen, primary, Pearce, Celeste Leigh, primary, Levine, Douglas A., primary, Kjaer, Susanne Kruger, primary, Cramer, Daniel, primary, Flanagan, James M., primary, Phelan, Catherine M., primary, Brown, Robert, primary, Massuger, Leon F.A.G., primary, Song, Honglin, primary, Doherty, Jennifer A., primary, Krakstad, Camilla, primary, Liang, Dong, primary, Odunsi, Kunle, primary, Berchuck, Andrew, primary, Jensen, Allan, primary, Lubiński, Jan, primary, Nevanlinna, Heli, primary, Bean, Yukie T., primary, Lurie, Galina, primary, Ziogas, Argyrios, primary, Walsh, Christine, primary, Despierre, Evelyn, primary, Brinton, Louise, primary, Hein, Alexander, primary, Rudolph, Anja, primary, Dansonka-Mieszkowska, Agnieszka, primary, Olson, Sara H., primary, Harter, Philipp, primary, Tyrer, Jonathan, primary, Vitonis, Allison F., primary, Brooks-Wilson, Angela, primary, Aben, Katja K., primary, Pike, Malcolm C., primary, Ramus, Susan J., primary, Wik, Elisabeth, primary, Cybulski, Cezary, primary, Lin, Jie, primary, Sucheston, Lara, primary, Edwards, Robert, primary, McGuire, Valerie, primary, Lester, Jenny, primary, du Bois, Andreas, primary, Lundvall, Lene, primary, Wang-Gohrke, Shan, primary, Szafron, Lukasz M., primary, Lambrechts, Sandrina, primary, Yang, Hannah, primary, Beckmann, Matthias W., primary, Pelttari, Liisa M., primary, Van Altena, Anne M., primary, van den Berg, David, primary, Halle, Mari K., primary, Gentry-Maharaj, Aleksandra, primary, Schwaab, Ira, primary, Chandran, Urmila, primary, Menkiszak, Janusz, primary, Ekici, Arif B., primary, Wilkens, Lynne R., primary, Leminen, Arto, primary, Modugno, Francesmary, primary, Friel, Grace, primary, Rothstein, Joseph H., primary, Vergote, Ignace, primary, Garcia-Closas, Montserrat, primary, Hildebrandt, Michelle A.T., primary, Sobiczewski, Piotr, primary, Kelemen, Linda E., primary, Pharoah, Paul D.P., primary, Moysich, Kirsten, primary, Knutson, Keith L., primary, Cunningham, Julie M., primary, Fridley, Brooke L., primary, and Goode, Ellen L., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results